Mirum Pharmaceuticals, Inc.
MIRM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2,905 | -$5,861 | -$14,677 | -$23,790 |
| Dep. & Amort. | $6,062 | $6,056 | $6,052 | $6,056 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $18,468 | $15,803 | $13,251 |
| Change in WC | $12,145 | -$6,556 | -$11,297 | -$1,682 |
| Other Non-Cash | $18,569 | -$67 | $2,158 | $1,097 |
| Operating Cash Flow | $39,681 | $12,040 | -$1,961 | -$5,068 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$187 | -$126 | -$41 | -$20 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$20,860 | -$31,537 | -$33,526 | -$11,483 |
| Inv. Sales/Matur. | $18,820 | $25,064 | $17,433 | $12,144 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$2,227 | -$6,599 | -$16,134 | $641 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $16,096 | $8,688 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $6,359 | $5,340 |
| Financing Cash Flow | $16,096 | $8,688 | $6,359 | $5,340 |
| Forex Effect | $349 | $2,226 | $1,055 | -$1,379 |
| Net Chg. in Cash | $53,899 | $16,355 | -$10,681 | -$466 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $228,122 | $212,247 | $222,928 | $223,394 |
| End Cash | $282,021 | $228,602 | $212,247 | $222,928 |
| Free Cash Flow | $39,494 | $11,914 | -$2,002 | -$5,088 |